Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HANFSTEIN, Benjamin")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 7 of 7

  • Page / 1
Export

Selection :

  • and

ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemiaERNST, Thomas; HOFFMANN, Jana; ERBEN, Philipp et al.Haematologica (Roma). 2008, Vol 93, Num 9, pp 1389-1393, issn 0390-6078, 5 p.Article

KRAS AND BRAF MUTATIONS AND PTEN EXPRESSION DO NOT PREDICT EFFICACY OF CETUXIMAB-BASED CHEMORADIOTHERAPY IN LOCALLY ADVANCED RECTAL CANCERERBEN, Philipp; STROBEL, Philipp; HOCHHAUS, Andreas et al.International journal of radiation oncology, biology, physics. 2011, Vol 81, Num 4, pp 1032-1038, issn 0360-3016, 7 p.Article

Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IVHEHLMANN, Rüdiger; MÜLLER, Martin C; SCHNITTGER, Susanne et al.Journal of clinical oncology. 2014, Vol 32, Num 5, pp 415-423, issn 0732-183X, 9 p.Article

Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicityHÄRTEL, Nicolai; KLAG, Thomas; HANFSTEIN, Benjamin et al.Journal of cancer research and clinical oncology. 2012, Vol 138, Num 2, pp 203-212, issn 0171-5216, 10 p.Article

Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapyHANFSTEIN, Benjamin; MÜLLER, Martin C; KREIL, Sebastian et al.Haematologica (Roma). 2011, Vol 96, Num 3, pp 360-366, issn 0390-6078, 7 p.Article

Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IVFABARIUS, Alice; LEITNER, Armin; JUNG-MUNKWITZ, Susanne et al.Blood. 2011, Vol 118, Num 26, pp 6760-6768, issn 0006-4971, 9 p.Article

ABL-kinase domain point mutation as a cause of imatinib (STI571) resistance in CML patient who progress to myeloid blast crisisSACHA, Tomasz; HOCHHAUS, Andreas; SKOTNICKI, Aleksander B et al.Leukemia research. 2003, Vol 27, Num 12, pp 1163-1166, issn 0145-2126, 4 p.Article

  • Page / 1